Guided Occupational Therapist Cognitive Interventions in Critically Ill Patients
GOTCI
1 other identifier
interventional
70
1 country
1
Brief Summary
Title: Guided Occupational Therapist (OT) Cognitive Interventions for Critically Ill Patients Short Title: GOTCI Methodology: Randomized Control Trial Study Duration: 12-15 months Study Centre: Single Center - South Health Campus, ICU, Calgary, Alberta, Canada Objectives: The aim for this study is to evaluate the effect of specific OT guided cognitive interventions on delirium in adult critically ill patients. Number of Subjects: 112 Primary Outcome: Delirium Prevalence and Duration Secondary Outcomes: Cognitive function, physical function, quality of life, ICU length of stay, hospital length of stay and days of mechanical ventilation. Inclusion Criteria: Adult Critically Ill Patients admitted to South Health Campus ICU, Calgary, Alberta Type of Intervention: OT guided cognitive intervention based on RASS score Dose: One on one therapeutic sessions with an OT. Five days a week, Monday to Friday, between 0800-1600. There will be twice daily sessions for 20 minutes each. Duration of administration: Cognitive Therapy to be initiated Monday to Friday, for the duration of participant ICU admission. Reference therapy: Standard of care within the Department of Critical Care Medicine in Calgary is delirium prevention strategies using the ABCDEF bundled approach. Statistical Methodology: Descriptive statistics (mean, median, proportion) will be employed to describe the study population. The primary outcome of delirium prevalence will be explored using multivariable logistic regression, which will provide an estimate of the odds ratio and accompanying 95% confidence intervals. Both per protocol and intent to treat analyses will be performed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 18, 2018
CompletedFirst Posted
Study publicly available on registry
July 30, 2018
CompletedStudy Start
First participant enrolled
June 15, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2020
CompletedDecember 8, 2020
December 1, 2020
1.5 years
June 18, 2018
December 5, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Delirium Prevalence and Duration
Ever Delirium: Measured using the Intensive Care Delirium Screening Checklist (ICDSC). If the patient has a positive score in the ICDSC at any point during the patient's ICU stay then the patient is considered to have delirium and qualifies for Ever Delirium. Delirium Duration: Number of days the patient has a positive score on the ICDSC. This does not have to be consecutive days.
From date of patient enrolment to ICU discharge, an average of 6.7 days.
Secondary Outcomes (6)
Cognitive Function
Measured within 24 hours of patient ICU admission and again after the treatment period is completed which is an average of 6.7 days.
ICU length of stay
ICU admission date to ICU discharge date is the time the patient will be given the treatment which is an average of 6.7 days.
Physical Function
Measured within 48 hours of ICU admission and again after the treatment period is completed which is an average of 6.7 days.
Quality of Life using the EQ5D-5L (EuroQual 5 Dimensions-5 Levels). This is a health quality of life measure assessing five domains; mobility, self-care, usual activities, pain/discomfort and anxiety/depression.
Measured after the treatment period is completed (within 24 hours of discharge) which is an average of 6.7 days.
Days of Mechanical Ventilation
Measured on day 1 of mechanical ventilation through to day of extubation (cessation of mechanical ventilation), an average of 4 days.
- +1 more secondary outcomes
Study Arms (2)
OT Guided Cognitive Interventions
EXPERIMENTALOccupational Therapy interventions will be adjusted according to the patient's Richmond Agitation and Sedation Scale (RASS).
Usual Care
NO INTERVENTIONThis will be the standard of care currently provided for delirium prevention within the Department of Critical Care Medicine in Calgary using the ABCDEF bundled approach.
Interventions
RASS is defined as the level of sedation and agitation of a patient. Cognitive interventions are evidence based strategies that enhance the cognition of patients and include memory training using visual imagery; metacognitive training using self-awareness and self-regulation approaches for recovery of executive functioning; and neuropsychological rehabilitation to help improve cognitive and functional deficits. Interventions will be adjusted according to the RASS score. Cognitive interventions include discussion of patient status and education of family around reorientation, cognitive screening and graded exercises according to patient ability. The deepest levels of sedation and highest levels of agitation will be included in the intervention arm. Interventions will be provided by the Occupational Therapist; Monday to Friday, BID, 20 minutes per session, for the duration of ICU admission.
Eligibility Criteria
You may qualify if:
- Adult medical/surgical critically ill patients admitted to the South Health Campus ICU in Calgary, Alberta during designated 6-month study period.
You may not qualify if:
- Primary Direct Brain Injury
- Prior diagnosis of dementia-related illness
- Prior diagnosis of developmental disability
- Pre-existing cognitive impairment
- Requiring palliative care
- In ICU for less than 48 hours
- Non-English speaking
- Severe communication disorders
- Non-critically ill Plasma Exchange Therapy patients
- Severe hearing or visual impairment
- ICU to ICU transfers
- COVID-19 positive patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
South Health Campus Intensive Care Unit
Calgary, Alberta, T3M1M4, Canada
Related Publications (8)
Lewin JJ 3rd, LeDroux SN, Shermock KM, Thompson CB, Goodwin HE, Mirski EA, Gill RS, Mirski MA. Validity and reliability of The Johns Hopkins Adapted Cognitive Exam for critically ill patients. Crit Care Med. 2012 Jan;40(1):139-44. doi: 10.1097/CCM.0b013e31822ef9fc.
PMID: 21926576BACKGROUNDHuang M, Chan KS, Zanni JM, Parry SM, Neto SG, Neto JA, da Silva VZ, Kho ME, Needham DM. Functional Status Score for the ICU: An International Clinimetric Analysis of Validity, Responsiveness, and Minimal Important Difference. Crit Care Med. 2016 Dec;44(12):e1155-e1164. doi: 10.1097/CCM.0000000000001949.
PMID: 27488220BACKGROUNDHerdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, Bonsel G, Badia X. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011 Dec;20(10):1727-36. doi: 10.1007/s11136-011-9903-x. Epub 2011 Apr 9.
PMID: 21479777BACKGROUNDBergeron N, Dubois MJ, Dumont M, Dial S, Skrobik Y. Intensive Care Delirium Screening Checklist: evaluation of a new screening tool. Intensive Care Med. 2001 May;27(5):859-64. doi: 10.1007/s001340100909.
PMID: 11430542BACKGROUNDvan den Boogaard M, Schoonhoven L, Maseda E, Plowright C, Jones C, Luetz A, Sackey PV, Jorens PG, Aitken LM, van Haren FM, Donders R, van der Hoeven JG, Pickkers P. Recalibration of the delirium prediction model for ICU patients (PRE-DELIRIC): a multinational observational study. Intensive Care Med. 2014 Mar;40(3):361-9. doi: 10.1007/s00134-013-3202-7. Epub 2014 Jan 18.
PMID: 24441670BACKGROUNDWassenaar A, Rood P, Boelen D, Schoonhoven L, Pickkers P, van den Boogaard M. Feasibility of Cognitive Training in Critically Ill Patients: A Pilot Study. Am J Crit Care. 2018 Mar;27(2):124-135. doi: 10.4037/ajcc2018467.
PMID: 29496769BACKGROUNDDeemer K, Zjadewicz K, Fiest K, Oviatt S, Parsons M, Myhre B, Posadas-Calleja J. Effect of early cognitive interventions on delirium in critically ill patients: a systematic review. Can J Anaesth. 2020 Aug;67(8):1016-1034. doi: 10.1007/s12630-020-01670-z. Epub 2020 Apr 24.
PMID: 32333291BACKGROUNDDeemer K, Myhre B, Oviatt S, Parsons M, Watson M, Zjadewicz K, Soo A, Fiest K, Posadas-Calleja J. Occupational therapist-guided cognitive interventions in critically ill patients: a feasibility randomized controlled trial. Can J Anaesth. 2023 Jan;70(1):139-150. doi: 10.1007/s12630-022-02351-9. Epub 2022 Nov 16.
PMID: 36385466DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stephanie Oviatt, MScPT PT
Alberta Health services
- PRINCIPAL INVESTIGATOR
Michelle Parsons, BHScPT PT
Alberta Health services
- PRINCIPAL INVESTIGATOR
Kirsten Fiest, PhD
University of Calgary, Alberta Health Services
- PRINCIPAL INVESTIGATOR
Karolina Herold, MN RN
Alberta Health services
- PRINCIPAL INVESTIGATOR
Juan Posadas, MD
University of Calgary, Alberta Health Services
- PRINCIPAL INVESTIGATOR
Brittany Myhre, MScOT OT
Alberta Health services
- PRINCIPAL INVESTIGATOR
Andrea Soo, PhD
University of Calgary
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- All investigators, with the exception of the occupational therapist, will be blinded to participant randomization.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Critical Care Nurse Practitioner
Study Record Dates
First Submitted
June 18, 2018
First Posted
July 30, 2018
Study Start
June 15, 2019
Primary Completion
November 30, 2020
Study Completion
November 30, 2020
Last Updated
December 8, 2020
Record last verified: 2020-12
Data Sharing
- IPD Sharing
- Will not share